Lebrikizumab Shows Strong Efficacy and Safety in Atopic Dermatitis: Study
Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease that significantly impacts quality of life and often requires systemic therapies for patients with moderate-to-severe disease. With increasing focus on targeted biologic therapies, anti–IL-13 monoclonal antibodies have emerged as a promising treatment option for patients inadequately controlled with conventional therapies. Findings from the BIOREP registry […]